PB RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (1996) 20: 452-454. doi: 10.1192/pb.20.8.452
© 1996 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaplin, R.
Right arrow Articles by McGuigan, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chaplin, R.
Right arrow Articles by McGuigan, S.

Antipsychotic dose: from research to clinical practice

Robert Chaplin, Senior Registrar in Psychiatry*

St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE

Sean McGuigan, Formerly Head of Biostatistics Department

Department of Mental Health Sciences, St. George's Hospital Medical School

* Correspondence

A case note study of antipsychotic prescribing in an inner London hospital showed that although doses of individual drugs were below the British National Formulary limits, polypharmacy occurred in a third of cases. Multiple regression analysis showed high doses were associated with a current risk to the self or others and increasing number of previous admissions in patients with mania and treatment non-responsiveness in schizophrenia.




This article has been cited by other articles:


Home page
Psychiatr. Bull.Home page
P. Lelliott, C. Paton, M. Harrington, M. Konsolaki, T. Sensky, and C. Okocha
The influence of patient variables on polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients
Psychiatr. Bull., November 1, 2002; 26(11): 411 - 414.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Bull.Home page
M. Harrington, P. Lelliott, C. Paton, C. Okocha, R. Duffett, and T. Sensky
The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UK
Psychiatr. Bull., November 1, 2002; 26(11): 414 - 418.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Bull.Home page
A. Wilkie, N. Preston, and R. Wesby
High dose neuroleptics -- who gives them and why?
Psychiatr. Bull., May 1, 2001; 25(5): 179 - 183.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1996 The Royal College of Psychiatrists.